OSIC Executive Director Elizabeth Estes discusses the power of OSIC and its plans for the future.
The Open Source Imaging Consortium (OSIC) is working to democratize medicine by giving OSIC clinicians and members everywhere the ability to access and benefit from the same technology and information as those affiliated with major research centers. “If we can figure out how to drive collaboration in healthcare, we will change the paradigm,” says Executive Director Elizabeth Estes.
“We have a lot of smart, motivated, dedicated people together who want to see these patients have a different path. The technology is there for personalized medicine. The technology is there to make advances in rare disease,” says Elizabeth Estes, Open Source Imaging Consortium (OSIC) Executive Director.
For decades, the healthcare industry has lacked a long list of elements necessary to understand the nature of hundreds of rare diseases — industry cohesiveness and data transparency chief amongst them. With the help of PwC and Microsoft, one pioneering group of minds may have finally found a key part of the solution: an open-source approach to medical research.
A discussion with the Open Source Imaging Consortium (OSIC), Microsoft and PwC: See how data and analytics, AI and cloud will reshape the future of healthcare.
A first-of-its-kind open source medical imaging and data repository platform is highlighting new possibilities to help improve the speed and accuracy of diagnosis and help patients, providers and researchers better manage.
A large and multi-ethnic database, reported to be the first of its kind for rare lung diseases, is now compiling real-world clinical and imaging data on people with pulmonary fibrosis (PF) and other interstitial lung diseases (ILDs) from centers across the globe.
OSIC member Dr. Sebastian Schmidt discusses how OSIC is changing the game in the fight against interstitial lung disease.
OSIC’s Pulmonary Fibrosis Progression Challenge is announced.
The launch of OSIC is announced.
